Open AccessCalcium Antagonists and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study
Author(s) -
Vivian M. Abascal,
Martin G. Larson,
Jane C. Evans,
Ana T. Blohm,
Kim A. Poli,
Daniel Levy
Publication year - 1998
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.158.17.1882
Subject(s) - medicine , framingham heart study , hazard ratio , framingham risk score , confidence interval , blood pressure , proportional hazards model , cardiology , cohort , heart failure , disease
Several recent studies have suggested that calcium antagonist drugs, which are widely used for the treatment of hypertension, are associated with increased risk of cardiovascular disease. These studies have cast doubts on the long-term safety of calcium antagonists.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom